this outfit distributes drugs that caude autoimmune diseases by depressing the level of tnf alpha rather than increading it. these guys sell snake oil. while there may be a few minds in the outfit they are likely to be overruled. what can you expect from an an outfit that has been intellectually beaten by a woman snd an italian and has failed to admit to the hsrms they have caused snd continue to cause.
let them be first in line to try their oen vaccine.
see faustmanlab.org
pubmed.org ristori + bcg
uspto.gov inventor search faustman
google iacocca + faustman
Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use
Johnson & Johnson and BARDA Together Commit More than $1 Billion to Novel Coronavirus Vaccine Research and Development; Company Expects to Initiate Phase 1 Human Clinical Studies of Vaccine Candidate at Latest by September 2020
Johnson & Johnson Will Establish New U.S. Vaccine Manufacturing Capabilities and Additional Production Capacity Outside the U.S. to Begin Production at Risk to Help Ensure Global Vaccine Supply
Philanthropy
Johnson became involved in charitable organizations full-time in the 1980s. He is a member of the Council on Foreign Relations. His family has been affected by both lupus and juvenile diabetes, which motivated Johnson to take a role in raising funds to prevent, treat, and cure autoimmune diseases. He has led efforts on Capitol Hill and at the National Institutes of Health to increase research funding for these diseases,[6] and personally contributed to causes related to diabetes, after his daughter, Casey, was diagnosed with the disease. He started a research foundation, the Alliance for Lupus Research, after his daughter Jaime was found to have lupus.[7]
NEW BRUNSWICK, N.J., March 30, 2020 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced the selection of a lead COVID-19 vaccine candidate from constructs it has been working on since January 2020; the significant expansion of the existing part
see aldo
A Vaccine From The 1920s Is Now Being Tested For Use Against The Coronavirus Pandemic
Researchers in a handful of countries are testing a century-old tuberculosis vaccine to see if it can give a boost to the immune system to help it fight off the novel coronavirus now causing the COVID-19 pandemic.
Clinical trials of the Bacille Calmette-Guerin (BCG) vaccine, which was first developed in the early 1920s,are planned in Europe and Australia to see if it can help reduce the prevalence and severity of COVID-19 symptoms.
Researchers from the Murdoch Children’s Research Institute (MCRI) in Melbourne are currently working to enroll 4,000 healthcare workers from hospitals around Australia in one study.
Today In: Science
“This trial will allow the vaccine’s effectiveness against COVID-19 symptoms to be properly tested, and may help save the lives of our heroic frontline healthcare workers,” MCRI Director Professor Kathryn North said in a release.
No comments:
Post a Comment